CD44 and breast carcinoma: To investigate the effect of miR-206 on CALR expression in human breast cancer stem cell, the breast cancer stem cells were firstly sorted and collected as CD44+ and CD24+ positive population and then were transfected with 30, 50 and 70nM of miR-206 for 48 hours.